文献速递产科母胎医学

乳腺癌诊断后1年及以上妊娠的产科与新生儿结局

Obstetric and Neonatal Outcomes 1 or More Years After a Diagnosis of Breast Cancer.
PubMed 文献 · Obstet Gynecol · 2022-11-02

基于加州癌症登记与全州卫生规划数据的人群研究,比较553例乳腺癌诊断后12个月及以上受孕的活产与匹配无癌史女性的活产。乳腺癌史与早产、小于胎龄儿及严重母亲疾病无显著关联,但剖宫产几率升高(OR 1.25;95% CI 1.03-1.53),新生儿疾病几率未升高。

要点

  • 乳腺癌诊断后1年及以上受孕者早产(<37周)几率与无癌史女性无显著差异。
  • 乳腺癌史女性剖宫产几率升高(OR 1.25;95% CI 1.03-1.53)。
  • 新生儿疾病几率未升高(OR 1.15;95% CI 0.81-1.62)。

核心结论

  • 受精前1年及以上有乳腺癌史与产科及新生儿并发症无强关联。

研究设计与样本

  • 基于加州癌症登记与加州全州卫生规划发展部数据集链接的人群研究,比较有乳腺癌史女性(病例组)与匹配无癌史女性(对照组)的活产。
  • 病例组为2000年1月1日至2012年12月31日期间18-45岁诊断I-III期乳腺癌、且在诊断后12个月及以上受孕者;对照组为2000-2012年分娩、无乳腺癌史且协变量匹配的女性。
  • 30021例18-45岁I-III期乳腺癌患者中553例符合研究纳入标准。
  • 主要结局为小于37周早产;次要结局包括小于32周早产、小于胎龄儿(SGA)、剖宫产、严重母亲疾病及新生儿疾病。
  • 亚组分析评估初始治疗至受精时间及孕前接受额外辅助治疗对结局的影响。

主要发现

  • 有乳腺癌史女性与匹配对照组小于37周早产几率相似(OR 1.29;95% CI 0.95-1.74)。
  • 小于32周早产几率相似(OR 0.77;95% CI 0.34-1.79)。
  • 分娩SGA新生儿几率相似(小于第5百分位:OR 0.60;95% CI 0.35-1.03;小于第10百分位:OR 0.94;95% CI 0.68-1.30)。
  • 严重母亲疾病几率相似(OR 1.61;95% CI 0.74-3.50)。
  • 有乳腺癌史患者剖宫产几率较高(OR 1.25;95% CI 1.03-1.53),但其子代新生儿疾病几率未较对照组升高(OR 1.15;95% CI 0.81-1.62)。

关键数值与推荐

  • 病例组纳入标准:2000年1月1日至2012年12月31日期间18-45岁诊断I-III期乳腺癌,且诊断后12个月及以上受孕。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate obstetric and neonatal outcomes of the first live birth conceived 1 or more years after breast cancer diagnosis. METHODS: We performed a population-based study to compare live births between women with a history of breast cancer (case group) and matched women with no cancer history (control group). Individuals in the case and control groups were identified using linked data from the California Cancer Registry and California Office of Statewide Health Planning and Development data sets. Individuals in the case group were diagnosed with stage I-III breast cancer at age 18-45 years between January 1, 2000, and December 31, 2012, and conceived 12 or more months after breast cancer diagnosis. Individuals in the control group were covariate-matched women without a history of breast cancer who delivered during 2000-2012. The primary outcome was preterm birth at less than 37 weeks of gestation. Secondary outcomes were preterm birth at less than 32 weeks of gestation, small for gestational age (SGA), cesarean delivery, severe maternal morbidity, and neonatal morbidity. Subgroup analyses were used to assess the effect of time from initial treatment to fertilization and receipt of additional adjuvant therapy before pregnancy on outcomes of interest. RESULTS: Of 30,021 women aged 18-45 years diagnosed with stage I-III breast cancer during 2000-2012, 553 met the study inclusion criteria. Those with a history of breast cancer and matched women in the control group had similar odds of preterm birth at less than 37 weeks of gestation (odds ratio [OR], 1.29; 95% CI 0.95-1.74), preterm birth at less than 32 weeks of gestation (OR 0.77; 95% CI 0.34-1.79), delivering an SGA neonate (less than the 5th percentile: OR 0.60; 95% CI 0.35-1.03; less than the 10th percentile: OR 0.94; 95% CI 0.68-1.30), and experiencing severe maternal morbidity (OR 1.61; 95% CI 0.74-3.50). Patients with a history of breast cancer had higher odds of undergoing cesarean delivery (OR 1.25; 95% CI 1.03-1.53); however, their offspring did not have increased odds of neonatal morbidity compared with women in the control group (OR 1.15; 95% CI 0.81-1.62). CONCLUSION: Breast cancer 1 or more years before fertilization was not strongly associated with obstetric and neonatal complications.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Jorgensen K, Nitecki R, Nichols HB, et al. Obstetric and Neonatal Outcomes 1 or More Years After a Diagnosis of Breast Cancer. Obstet Gynecol. 2022. PMID: 36357983. doi:10.1097/AOG.0000000000004936

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。